Symposia
The Coalition of Pharmacists Caring for Aging Canadians Scientific Meeting
Saturday October 27, 2018
Amgen Breakfast Symposium (Platinum Sponsor)
Topic: Falling Between the Cracks – an Update on Osteoporosis
Speaker: Dr. Anne Braun BSc MD MSc FRCPC FACP
E. Anne Braun BSc MD MSc FRCPC FACP is currently an Associate Clinical Professor in the Departments of Medicine and Psychiatry at McMaster University. She graduated from McGill University with Great Distinction in Neurobiology and Comparative Physiology. She then completed her MD and then an MSc in Medical Sciences at McMaster. Following this were her Royal College certifications in Internal Medicine and Geriatric Medicine as well as completing Internal Medicine specialty exams and Fellowship requirements for the American College.
She is actively involved in teaching both in the undergraduate MD programme and postgraduate programme at McMaster. She has had a number of publications including author of 2 chapters in the Geriatric Medicine Handbook published through McMaster University. Current research projects involve osteoporosis in both community dwelling seniors as well as those in Long Term Care. Major areas of expertise are osteoporosis, dementia, polypharmacy and late onset psychiatric disturbances.
Current clinical roles are as a consultant geriatrician in Halton Healthcare, St Joseph’s Hospital Hamilton, Niagara Health System, Hotel Dieu- Shaver Rehabilitation Hospital in St Catharines and Delhi Community Health Centre. She has held numerous positions of leadership over the years involving geriatrics and residency education.
Abstract: Osteoporosis – Are Residents/Elderly Falling Between the Cracks?
Only 20% of patients are treated in Canada for Osteoporosis, there is a severe care gap. Fractures in LTC are increasing 2-4 x higher than that of the community and 60-80% of residents in LTC have Osteoporosis. The majority of residents are Undiagnosed and 30% of residents today have a vertebral fracture. There are high mortality rates that are associated with fracture – Almost 50% of fractures occur at the vertebrae and hip and are associated with huge rates of morbidity and mortality
Janssen Lunch Symposium (Silver Sponsor)
Topic: Practical Guidelines in the Management of Type 2 Diabetes
Speaker: Dr. Robert Schlosser
Dr. Robert Schlosser completed his medical school training at the University of Toronto (1987) as well as Internal Medicine and Endocrinology fellowships at the University of Western Ontario (1988-1993). He has been certified in Endocrinology and Metabolism by the Royal College of Physicians and the American Board of Internal Medicine since 1992. Presently, Dr. Schlosser is on staff at Mackenzie Health Hospital in Richmond Hill and co-director of the LMC Endocrinology Center in Thornhill. Since 1998, Dr. Schlosser has participated in several international Clinical Research studies, including investigational therapies for the treatment of Diabetes, Obesity, Hypertension and Hyperlipidemia. He is an active member of the Canadian and American Diabetes Associations, the Canadian Society of Endocrinology and Metabolism, and the Endocrine Society. In addition, he is a well-known educator on the medical complications associated with diabetes, hyperlipidemia, osteoporosis, and thyroid dysfunction, and has given numerous public and professional talks on these subjects throughout his career.
Learning Objectives:
- Understand the goals for T2DM patients with and without cardiovascular disease.
- Review the data informing of the Clinical Practice Guidelines update.
- Review Clinical implications with regards to diabetic treatment within the aged.
- Apply the clinical implications of the guidelines update to different patient cases throughout the continuum of diabetes progression.
Boehringer-Ingelheim Dinner Symposium (Silver Sponsor)
Topic: Navigating COPD
Speaker: Dr. Kenneth R. Chapman, M.D., M.Sc., FRCPC, FACP, FERS
Dr. Chapman is Director of the Asthma and Airway Centre of the University Health Network, President of the Canadian Network for Respiratory Care and Director of the Canadian Registry for Alpha-1 Antitrypsin Deficiency. A graduate of the University of Toronto and a former member of the faculty at Case Western Reserve University, he is now a Professor of Medicine at the University of Toronto.
Dr. Chapman is an internationally respected researcher in the field of asthma, COPD and airway diseases; his publications have appeared in the New England Journal of Medicine and the Lancet. The titles of more than 600 publications ranged from "Emergency medical services for outdoor rock music festivals" to "The effect of posture on thoracoabdominal movements during progressive hyperoxic hypercapnia in conscious man". With more the 15,000 citations to his work, Professor Chapman is in the top 1% of cited medical researchers.
He chaired Canada’s first Consensus Conference to establish Canadian guidelines for the management of COPD. Professor Chapman is the inaugural holder of the CIHR-GSK Research Chair in Respiratory Health Care Delivery at the University Health Network and was one of five Canadian respiratory physicians awarded Fellowship in the European Society in its Inaugural year.
Learning Objectives
By taking part in this program, participants will:
- Review the diagnosis of COPD
- Understand the role of the three main pharmacologic agents used in the treatment of COPD
- Examine a simplified strategy for managing COPD optimally
- Discuss action plans for COPD exacerbations